Skip to main content
. 2020 Dec 4;2020(1):512–517. doi: 10.1182/hematology.2020000135

Table 3.

Fatalities associated with incompatible platelet transfusions reported to the US Food and Drug Administration from 2007 to 2017

Fiscal year Patient ABO Platelet ABO Antibody titer
2015 B A Anti-B (1:2048)
2014 A O Anti-A (1:2048)
2014 AB O* Anti-A and anti-B (1:128)Anti-A and anti-B (1:128)
O*
2012 A O† “High titer”Data not provided
O†
2011 A‡ O Anti-A 1:512 for IgM and 1:2048 for IgG25
2008 B‡ O “High titer”Data not provided.

IgG, immunoglobulin G; IgM, immunoglobulin M.

*

Recipient received 2 units of group O platelets from the same donor.

Recipient received 2 units of group O platelets from 2 different donors.

Recipient’s blood group recently changed following ABO-mismatched hematopoietic stem cell transplant.